How to buy Quest Diagnostics Incorporated (DGX) shares in Australia

Learn how to easily invest in Quest Diagnostics Incorporated shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Quest Diagnostics Incorporated (DGX) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$134.23 after a previous close of US$133.87. During the day the price has varied from a low of USD133.71 to a high of USD135.15. The latest price was USD135.04 (25 minute delay). Quest Diagnostics Incorporated is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in Quest Diagnostics Incorporated

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Quest Diagnostics Incorporated. Find the share by name or ticker symbol: DGX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Quest Diagnostics Incorporated reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$133.87, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Quest Diagnostics Incorporated, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Quest Diagnostics Incorporated. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Quest Diagnostics Incorporated stock price (NYSE:DGX)

Use our graph to track the performance of DGX stocks over time.

Quest Diagnostics Incorporated shares at a glance

Information last updated 2021-07-09.
OpenUS$134.23
HighUS$135.15
LowUS$133.71
CloseUS$135.04
Previous closeUS$133.87
Change US$1.17
Change % 0.874%
Volume 619,612
Information last updated 2022-01-17.
52-week rangeUS$111.8094 - US$174.16
50-day moving average US$156.6408
200-day moving average US$143.8363
Target priceUS$169.07
PE ratio 8.5553
Dividend yield US$2.42 (1.74%)
Earnings per share (TTM) US$16.633

Where to buy Quest Diagnostics Incorporated stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
US$0
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
US$0
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
US$0
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares, ETFs
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
CMC Markets Invest
US$0
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
Saxo Capital Markets (Classic account)
US$4
1%
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
SelfWealth (Basic account)
US$9.5
0.60%
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Quest Diagnostics Incorporated share growth calculator

US$

Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Quest Diagnostics Incorporated price performance over time

Historical closes compared with the last close of $135.04

1 week (2022-01-13) -6.88%
1 month (2021-12-23) -19.16%
3 months (2021-10-22) -7.82%
6 months (2021-07-23) -3.15%
1 year (2021-01-22) 8.50%
2 years (2020-01-23) 25.05%
3 years (2019-01-23) 56.46%
5 years (2017-01-23) 48.28%

Is Quest Diagnostics Incorporated under- or over-valued?

Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quest Diagnostics Incorporated's P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Quest Diagnostics Incorporated shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Quest Diagnostics Incorporated's PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 40.1904. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Quest Diagnostics Incorporated's EBITDA

Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.1 billion (£2.3 billion).

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

Quest Diagnostics Incorporated financials

Revenue TTM US$11 billion
Operating margin TTM 24.75%
Gross profit TTM US$3.7 billion
Return on assets TTM 12.33%
Return on equity TTM 34.92%
Profit margin 19.77%
Book value 51.967
Market capitalisation US$17.5 billion

TTM: trailing 12 months

Quest Diagnostics Incorporated's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Quest Diagnostics Incorporated's total ESG risk score

Total ESG risk: 18.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 12/31/2018) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Quest Diagnostics Incorporated's environmental score

Environmental score: 0.86/100

Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's social score

Social score: 10.42/100

Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Quest Diagnostics Incorporated's governance score

Governance score: 5.77/100

Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Quest Diagnostics Incorporated was last rated for ESG on: 2019-01-01.

Total ESG score 18.33
Total ESG percentile 16.26
Environmental score 0.86
Environmental score percentile 1
Social score 10.42
Social score percentile 1
Governance score 5.77
Governance score percentile 1
Level of controversy 3

Quest Diagnostics Incorporated share dividends

16%

Dividend payout ratio: 16.12% of net profits

Recently Quest Diagnostics Incorporated has paid out, on average, around 16.12% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 1.74% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.42 per share.

While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that Quest Diagnostics Incorporated is investing more in its future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 1 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 January 2022 (the "ex-dividend date").

Have Quest Diagnostics Incorporated's shares ever split?

Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 20 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.

Quest Diagnostics Incorporated share price volatility

Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as US$111.8094 up to US$174.16. A popular way to gauge a stock's volatility is its "beta".

DGX.US volatility(beta: 1.02)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 1.0218. This would suggest that Quest Diagnostics Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Quest Diagnostics Incorporated overview

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site